Dermatitis herpetiformis in a patient receiving infliximab for ankylosing spondylitis.
Marakli
Selma Sonmezoglu
SS
Uzun
Soner
S
Ozbek
Suleyman
S
Tuncer
Ilhan
I
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D003874:Dermatitis Herpetiformis / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D000069285:Infliximab; D008297:Male; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab